Hardeep Banwait

Hardeep Banwait is an accomplished clinical research professional with extensive experience in oncology and infectious disease. Currently serving as a Clinical Trial Lead for EMEA at Catalyst Clinical Research, LLC since September 2021, Hardeep has held significant roles including Consultant Clinical Project Manager at Eisai EMEA and Clinical Research Consultant at Basilea Pharmaceutica. Hardeep's background also includes managing clinical trials for Ebola vaccines in Sierra Leone with FHI 360 and the London School of Hygiene and Tropical Medicine, alongside work in biotechnology with F2G focused on developing a novel anti-fungal drug. Earlier experience includes positions with 3M and INC Research, emphasizing clinical trial management and new product introduction. Hardeep earned a BSc. (Hons) in Biomedical Science from Sheffield Hallam University.